StartUp Health

Founded in 2011, StartUp Health is dedicated to improving global health through collaboration with entrepreneurs. It invests in 'Health Transformers' across six continents, focusing on various health moonshots such as Access to Care, Cure Disease, and Mental Health. With over 330 companies in its portfolio, it's backed by prominent investors.

Joshua Cherry-Seto

Partner and CFO

Katya Hancock

Partner and Chief Impact Officer

Steven Krein JD

Managing Partner

Priya Reddy

Associate

Unity Stoakes

President

Past deals in Health Diagnostics

Medwise.ai

Seed Round in 2023
Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

Zen Sleep Technologies

Venture Round in 2022
Zen Sleep is to build better sleep hygiene for people suffering from sleep problems. It was located in Los Angeles, CA.

MIIST Therapeutics

Seed Round in 2022
MIIST Therapeutics focuses on advancing pulmonary drug delivery systems and digital platforms to improve inhaled drug therapies. The company is developing innovative technology aimed at facilitating smoking cessation and addressing the health risks associated with tobacco use. By creating inhaler technology that targets the deepest areas of the lungs, MIIST enables rapid absorption of medications. This approach aims to enhance the effectiveness of inhaled treatments for various health conditions, starting with smoking addiction, and ultimately seeks to reduce the significant health burdens related to tobacco consumption.

Momentum Health

Venture Round in 2022
Momentum Health is a digital health company founded in 2022 that specializes in remote scoliosis screening and monitoring. The company has developed an innovative application that utilizes three-dimensional imaging and artificial intelligence to analyze a simple fifteen-second video captured on a smartphone. This technology reconstructs a model of the torso to quantify asymmetries and predict curve progression, allowing physicians to conduct frequent, radiation-free assessments. By enabling timely observations, Momentum Health aims to reduce the risk of scoliosis progression and the associated health complications, including breast cancer risks.

Scan.com

Seed Round in 2022
Scan.com is a diagnostic imaging platform serving the United Kingdom and United States markets. It operates as a multi-sided platform that links outpatient diagnostic centers on the supply side with outpatient clinicians on the demand side, enabling clinicians to order imaging for patients. The platform aims to improve access to medical imaging by providing EMR-integrated workflow solutions that are free to use for referring clinicians, and it expands through local metro networks of imaging centers and referring clinicians.

Quickr Health

Angel Round in 2022
Quickr Health is a developer of a MedTech platform aimed at enhancing the efficiency of direct primary care providers. Its innovative platform combines features of electronic health records and customer relationship management, streamlining various processes such as appointment scheduling, health charts, and messaging services. By offering these integrated tools, Quickr Health empowers both healthcare providers and patients to manage and control their health data effectively, ultimately saving time and improving the quality of care. This focus on user-friendly solutions positions Quickr Health as a valuable resource in the healthcare technology landscape.

BrainScanology

Venture Round in 2022
BrainScanology Inc. specializes in advanced brain scanning analysis technology that aims to enhance the diagnostic capabilities of medical professionals, particularly in the fields of psychiatry and radiology. The company’s proprietary tool, ShapeGenie, significantly improves shape analysis at the cellular level without relying on traditional area or volume measurements. This innovative approach allows for more accurate diagnostics, addressing common challenges faced by radiologists due to mental fatigue. Additionally, BrainScanology's technology enables the early detection and monitoring of psychiatric disorders, such as dementia and schizophrenia, by providing annual assessments of disease progression. This reduces diagnostic uncertainty and facilitates the development of machine learning models for improved disease subtype identification. Overall, BrainScanology is committed to revolutionizing diagnostic processes in healthcare through its cutting-edge technology.

9amHealth

Series A in 2022
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Mammha

Venture Round in 2022
Mammha is an online healthcare platform dedicated to addressing maternal mental health. It offers a comprehensive solution for expecting mothers by providing remote mental health screening and facilitating referrals to appropriate resources. The platform connects patients with essential care and support services, enabling them to manage anxiety and improve their mental well-being. Through supportive counseling and regular check-ins, Mammha aims to help young mothers navigate the emotional challenges of pregnancy and postpartum life, fostering a healthier transition into motherhood.

Undahealth

Seed Round in 2022
Undahealth develops a telehealth platform that delivers personalized healthcare solutions aimed at addressing the widespread issue of chronic diseases. The company’s AI‑driven monitoring system focuses on gut health management, providing real‑time symptom tracking and tailored AI insights. Its platform integrates seamlessly with telehealth services and data analytics, enabling clinicians to offer proactive care and improve patient outcomes.

Everyplace Labs

Seed Round in 2021
Everyplace Labs develops automated point-of-care testing solutions. Their self-service kiosk enables patient-initiated or staff-assisted urine diagnostics, reducing bottlenecks and improving efficiency in acute care settings.

Diagnostikare

Venture Round in 2021
Diagnostikare is a Mexican digital health company offering accessible, high-quality primary care to underserved populations. It combines virtual and in-person services, delivering comprehensive care and holding top industry certifications.

Medwise.ai

Convertible Note in 2021
Medwise.ai operates a customizable search platform that uses natural language processing and artificial intelligence technologies to provide clinical decision support for doctors. Its real-world data offers insights to various healthcare stakeholders, enabling doctors to organize medical knowledge and enhance patient care outcomes.

Gabbi

Seed Round in 2021
Gabbi is a healthcare technology company that uses AI and clinical research to help women understand and proactively manage their health risks, with a focus on breast cancer risk, prevention, and early detection. The platform offers a lifetime risk assessment, personalized action plans, and virtual care options such as video appointments and chat, along with a community network that supports ongoing engagement and informed decision making.

Fortius Labs

Pre Seed Round in 2021
Founded in 2020 by experts in computer vision engineering and musculoskeletal healthcare, Fortius Labs is a healthtech company developing software to automate and objectify movement-based injury risk assessments. Using proprietary computer vision algorithms and Dynamic Biomechanical Assessment™, the platform analyzes 3D human motion from webcam or smartphone videos to identify injury risks and recommend personalized exercise progressions.

One Stop Wellness

Pre Seed Round in 2021
One Stop Wellness is a digital platform that encourages employees to embrace healthier lifestyles. It tracks chronic health risks and provides personalized guidance to enhance overall wellbeing, helping companies improve employee health and reduce healthcare costs.

Akenta Health

Venture Round in 2021
Akenta Health is a telehealth platform dedicated to providing accessible and culturally competent healthcare for the 63 million Latinos residing in the United States. The company operates as a digital health clinic focused on cardiovascular disease prevention, allowing patients to consult with doctors and receive diagnoses from the comfort of their homes. Akenta Health emphasizes personalized care by setting both macro and micro health goals, enabling patients to enhance their medical knowledge and improve their cardiovascular health. Through this approach, the company aims to empower individuals to take charge of their health and live healthier lives.

GritWell

Pre Seed Round in 2020
GritWell Ltd is a digital health platform that specializes in addressing chronic health conditions through a holistic approach. Founded in 2018 and based in San Francisco, the company connects patients with a variety of health professionals, including nutritionists, health coaches, and naturopathic doctors. GritWell's platform facilitates secure video consultations, direct messaging, and online scheduling, allowing for personalized treatment plans and credible advice tailored to individual needs. By focusing on root cause treatment rather than mere symptom management, GritWell employs clinically validated symptom assessments to guide patients toward appropriate care while integrating natural treatment options. This innovative approach aims to improve health outcomes by enabling patients to find practitioners who can address the underlying issues of their chronic symptoms, such as insomnia, migraines, and anxiety.

Inbox Health

Venture Round in 2020
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Attigo

Seed Round in 2020
Attigo specializes in improving health and business continuity in enterprises using superior and safe technology. The company was founded by artificial intelligence, computer vision, and deep learning experts and leaders in enterprises and health industries with a vision to empower health with an Attigo assistant.

AgeRate

Seed Round in 2020
AgeRate is a biotechnology company developing a platform to monitor aging in real time by applying predictive algorithms to multi-omic data. The platform provides insights into health and longevity, with initial offerings that enable individuals to track their biological aging and learn how lifestyle adjustments can influence aging tempo. In addition, AgeRate employs epigenetic testing that analyzes DNA methylation patterns to compare biological age with chronological age, supporting users in slowing the aging rate through evidence-based interventions such as diet and exercise.

LivNao

Seed Round in 2020
LivNao Technologies is a Vancouver-based company that utilizes deep learning technology to monitor and enhance mental health. By passively collecting data, LivNao's platform identifies early indicators of mental health changes before they impact performance and productivity. Once a deviation is detected, the company provides timely interventions tailored to individual health plans, promoting proactive mental health management. LivNao aims to improve the quality of life for individuals and organizations alike, enabling informed decision-making for healthcare systems and insurers. Committed to maintaining privacy and security, LivNao operates in full compliance with HIPAA regulations.

Virta Health

Series C in 2020
Virta Health is a San Francisco–based health technology company that specializes in treating type 2 diabetes through an online, physician-supported program. The company combines nutritional biochemistry, data science, and digital tools to deliver on-demand care via a continuous remote care platform, providing physicians and health coaches who guide patients to reduce blood sugar and lose weight without medications or surgery. Founded in 2014, Virta offers a treatment approach aimed at reversing type 2 diabetes and improving related metabolic and cardiovascular health.

AgeRate

Seed Round in 2020
AgeRate is a biotechnology company developing a platform to monitor aging in real time by applying predictive algorithms to multi-omic data. The platform provides insights into health and longevity, with initial offerings that enable individuals to track their biological aging and learn how lifestyle adjustments can influence aging tempo. In addition, AgeRate employs epigenetic testing that analyzes DNA methylation patterns to compare biological age with chronological age, supporting users in slowing the aging rate through evidence-based interventions such as diet and exercise.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Rose Health

Seed Round in 2020
Rose Health is a digital mental health company that uses artificial intelligence and machine learning to connect patients with suitable therapists and provide tools to support therapy. The platform keeps care providers and patients connected through technology, enabling personalized assessments, feedback, and ongoing monitoring. It employs deep technology for the early detection of depression and mood disorder symptoms, helping clinicians identify at‑risk individuals sooner and tailor interventions. The solution is designed to complement traditional therapy by streamlining referrals, tracking treatment progress, and facilitating coordinated care across care teams, with a focus on scalable, data‑driven insights to improve patient engagement and treatment outcomes.

Alerje

Seed Round in 2020
Alerje, Inc. is a Detroit-based company focused on enhancing the quality of life for individuals with food allergies. Founded in 2015, Alerje has developed an innovative emergency medicine and digital oral immunotherapy management platform. Central to its offerings is an epinephrine auto-injector that conveniently fits into a smartphone case, promoting better adherence and alert management for users. The company also provides a mobile application that allows users to create personalized food allergy profiles, share these profiles with caregivers and medical professionals, and filter recipes based on allergen information. Additionally, the app includes features for scanning grocery items to identify potential allergens, thus aiding families and healthcare providers in making informed dietary choices. Alerje's platform is validated by the National Science Foundation and aims to improve emergency response and overall management of food allergies.

Safely Health

Series A in 2019
Safely Health operates an online platform designed to promote safe sexual practices by enabling users to import their test results and verify their STD and COVID-19 status. Founded in 2015 and based in Los Angeles, the company aims to create a trusted, private, and secure environment for individuals seeking to share their health information with potential partners. Safely Health is not just an app but a comprehensive healthcare initiative that collaborates with leading healthcare organizations, including Quest and Labcorp, as well as public health entities like the CDC. By partnering with nonprofit organizations, influencers, and social media platforms, Safely Health seeks to empower users to take control of their sexual health and reduce the spread of STDs, ultimately fostering a safer and more enjoyable dating experience.

WellBrain

Venture Round in 2019
WellBrain is a digital behavioral health platform founded in 2015 and based in Pleasant Hill, California, that assesses, engages, and monitors patients to improve outcomes in chronic pain and mental health. The platform provides real-time cognitive assessment and treatment powered by artificial intelligence and machine learning, enabling clinicians to apply non-opioid modalities while addressing conditions such as depression, anxiety, and substance use. By delivering data-driven insights and tools for risk assessment and ongoing management, WellBrain supports clinicians in reducing the risk of painkiller addiction and guiding treatment decisions for patients with chronic pain.

Inbox Health

Seed Round in 2019
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Lactation Lab

Pre Seed Round in 2019
Lactation Lab analyzes breast milk samples to provide mothers with detailed nutritional insights. Their user-friendly reports help moms understand the composition of their milk, promoting informed decisions about infant nutrition.

Savonix

Non Equity Assistance in 2019
Savonix develops an evidence-based digital neuro-cognitive assessment and brain health platform. Its Savonix Mobile enables individuals to conduct clinically recognized cognitive assessments on smartphones or tablets, with results usable by patients, clinicians, employers, and healthcare providers to guide brain health decisions. The company offers a suite of tools to interpret results and support monitoring, diagnosis, and treatment planning. It has partnerships with New York University, CereScan, Proove Biosciences, Alkahest, and Senescence Life Sciences. Founded in 2014 and based in San Francisco, Savonix tests cognitive domains from memory to implicit learning, including a 3D game platform that derives novel metrics from in-app performance. The platform supports early detection of cognitive change and dementia risk, and serves doctors, researchers, insurers, and government clients with accessible, scalable cognitive screening.

Goldfinch Health

Seed Round in 2019
Goldfinch Health offers a perioperative care platform that improves surgical outcomes and reduces opioid use. The platform combines nurse-led navigation, multimodal pain management, and a proprietary preparation toolkit to support enhanced recovery protocols, lower costs, and improved postoperative care for patients and healthcare providers. By guiding patients through preoperative preparation, intraoperative coordination, and postoperative recovery, the company aims to reduce unnecessary opioid prescriptions and associated complications while helping employers and health systems deliver safer, more efficient perioperative care.

Responsum Health

Seed Round in 2019
Responsum Health develops disease-specific mobile apps, based on extensive research and patient collaboration. These apps aim to enhance patients' knowledge, boost self-confidence, address needs and concerns, and organize healthcare information.

SyncThink

Seed Round in 2019
SyncThink Inc. is a neuro-technology company based in Palo Alto, California, that specializes in eye-tracking technology for brain health analytics. Founded in 2009 by neurosurgeon Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a non-invasive, head-mounted eye-tracking system designed to provide medical professionals with objective metrics related to visual attention and dynamic orientation. EYE-SYNC performs a rapid, 60-second assessment to identify ocular motor impairments and vestibular dysfunction, which are critical components in concussion evaluation. This technology is utilized by various university athletic departments and medical facilities, including Stanford University and Massachusetts General Hospital, for brain health assessment and recovery monitoring. SyncThink's innovations are backed by numerous partnerships with leading research institutions and have received FDA approval, making them applicable in military and athletic contexts as well as in broader applications related to attention development and brain performance. The company holds multiple patents related to its technology and analytics, further solidifying its position in the neuro-diagnostics field.

Resility Health

Seed Round in 2018
Resility Health is a digital platform that assesses, monitors, and manages stress for individuals, families, employers, and healthcare providers. It combines stress-management techniques with biofeedback from wearable sensors and uses machine learning to create personalized training programs that continually adapt to the user. The platform supports on-the-job stress management, enhances coping skills and relationships, and mitigates the physical impacts of stress on medical conditions, with the aim of reducing chronic pain and anxiety and delivering better health outcomes at lower costs.

PerSoN Clinic

Seed Round in 2018
PerSoN Clinic is a virtual care platform operator offering comprehensive eHealth technology solutions. It provides PerSoN Care, holistic online counseling services, and PerSoN Clinic, software models for a turn-key SaaS-based virtual care environment.

Welwaze Medical

Seed Round in 2018
Welwaze Medical is focused on reducing breast cancer mortality through innovative medical solutions. The company has developed a disposable breast thermometric device designed for the early detection of breast diseases, including breast cancer. This non-invasive and non-powered device allows women to monitor their breast health quickly and conveniently. In addition to the device, Welwaze Medical employs an artificial intelligence model that provides predictive and personalized recommendations aimed at enhancing women's breast wellness. This comprehensive approach not only aids researchers and medical practitioners in improving care but also assists payers in optimizing costs associated with breast disease management. The device has received regulatory clearance from the FDA, the European Union, and various health authorities worldwide.

Savonix

Series A in 2018
Savonix develops an evidence-based digital neuro-cognitive assessment and brain health platform. Its Savonix Mobile enables individuals to conduct clinically recognized cognitive assessments on smartphones or tablets, with results usable by patients, clinicians, employers, and healthcare providers to guide brain health decisions. The company offers a suite of tools to interpret results and support monitoring, diagnosis, and treatment planning. It has partnerships with New York University, CereScan, Proove Biosciences, Alkahest, and Senescence Life Sciences. Founded in 2014 and based in San Francisco, Savonix tests cognitive domains from memory to implicit learning, including a 3D game platform that derives novel metrics from in-app performance. The platform supports early detection of cognitive change and dementia risk, and serves doctors, researchers, insurers, and government clients with accessible, scalable cognitive screening.

Safely Health

Venture Round in 2018
Safely Health operates an online platform designed to promote safe sexual practices by enabling users to import their test results and verify their STD and COVID-19 status. Founded in 2015 and based in Los Angeles, the company aims to create a trusted, private, and secure environment for individuals seeking to share their health information with potential partners. Safely Health is not just an app but a comprehensive healthcare initiative that collaborates with leading healthcare organizations, including Quest and Labcorp, as well as public health entities like the CDC. By partnering with nonprofit organizations, influencers, and social media platforms, Safely Health seeks to empower users to take control of their sexual health and reduce the spread of STDs, ultimately fostering a safer and more enjoyable dating experience.

TQIntelligence

Seed Round in 2018
TQIntelligence, Inc., established in 2016 and based in Atlanta, Georgia, specializes in voice-based artificial intelligence for mental health assessment. The company's platform integrates diverse data sources to provide cognitive insights, enabling risk stratification, tracking treatment outcomes, and personalized behavioral interventions. Key products include TQ-Intelligence, which offers insights from voice/speech analytics and other psychometrically validated instruments, and TQ Analytics, leveraging existing EMR data for actionable insights. The platform features machine learning analytics, knowledge graph, and real-time prediction capabilities to support healthcare professionals in diagnosing mental health issues more effectively, particularly for children who may struggle to communicate their distress.

LifeWIRE Group

Seed Round in 2018
LifeWIRE Group develops a secure, cloud-based messaging platform that connects healthcare providers, patients, and other stakeholders. The platform automates patient engagement through scripted, automated dialogues, ensuring HIPAA compliance and HITRUST certification. It facilitates patient outreach, follow-up, feedback, and compliance, driving cost reductions while enhancing clinical outcomes and efficiencies.

eko.ai

Pre Seed Round in 2018
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Oratel Diagnostics

Seed Round in 2018
Oratel Diagnostics, established in 2006 and based in Hammondsport, New York, specializes in developing diagnostic tools for mammalian fertility using plant pigment chemistry. The company's initial product is an ovulation detection test designed for dairy cattle, with plans to extend this technology to other livestock. Additionally, Oratel has developed saliva-based diagnostic devices that employ plant pigments to identify endometriosis and other reproductive disorders in women, aiding physicians in distinguishing pelvic pain causes and resolving fertility issues.

Cubismi

Seed Round in 2018
Cubismi is a physician-led grassroots AI-cloud company using human-centered design processes to build a first DecisionFlow-3D™ platform for clinical medicine — to deliver novel decision augmentation and decision intelligence experiences that will enable physicians to drive personalization of each patient’s care pathway. For cancer patients, the platform will deliver critical-need “street views” of tumor heterogeneity for better treatment selection and the potential for far more sensitive detection of early cancer. The platform leverages a cutting-edge “data fabric” informatics technology to anatomically structure data from a potentially unlimited array including medical imaging and all other health data.

LEA Labs

Seed Round in 2018
LEA Labs is an information technology company based in San Antonio, Texas, established in 2017. The company focuses on empowering individuals with chronic conditions through its innovative health management platform. Leveraging artificial intelligence and custom machine learning techniques, LEA Labs aims to predict and mitigate complications related to chronic diseases. Its platform provides a secure and decentralized ledger that allows users to maintain control over their health data while accessing vital information from various health record providers. This comprehensive approach facilitates better health condition management, enhancing the quality of life for individuals facing chronic health challenges.

FitTrace

Seed Round in 2018
FitTrace is a mobile application focused on optimizing the performance, health, and wellness of individuals by tracking and analyzing body composition information. Founded in 2014 by Mike DiChiappari, the company offers features such as basic body composition reporting, comparisons to professional athletes, online personal training, scan sharing, and access via mobile and web platforms. FitTrace caters to various user groups, including athletes, teams, fitness trainers, and youth sports participants. The platform stores body composition data and provides advanced insights and analytics to help users track progress over time, optimize performance, and improve injury recovery.

Trak

Series A in 2018
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

HealthTechApps

Seed Round in 2017
Founded in 2012, HealthTechApps specializes in developing neurotechnology platforms that empower individuals to track their health stories. Initially focusing on traumatic brain injuries, the company uses proprietary technology pairing short videos with AI and machine learning to capture concussion symptoms and triggers over time, enabling physicians to make informed decisions.

Fruit Street

Debt Financing in 2017
Fruit Street offers a virtual diabetes prevention program. It helps participants adopt healthier lifestyles to prevent type 2 diabetes through online classes, personalized tracking of diet and activity, and integration with wireless scales for progress monitoring.

Trak

Venture Round in 2017
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Curacase

Seed Round in 2017
Curacase is a diabetes management platform founded in 2016 and based in New York, New York. The company focuses on enhancing patient quality of life through its innovative technology, which offers real-time testing, data diagnostics, and actionable reports. By providing low-cost alerts, Curacase enables healthcare providers to make informed decisions and effectively manage diabetes care for their patients.

MetaLogics

Seed Round in 2017
MetaLogics is a company that specializes in a weight control platform designed to offer personalized, accurate, and validated metabolic information to both healthcare professionals and consumers. By integrating scientific research with advanced technology, MetaLogics equips individuals with the metabolic insights required to effectively balance calorie intake with calorie expenditure. This empowers users to develop and attain their weight management goals, ultimately fostering healthier lifestyle choices. The platform aims to enhance understanding of personal metabolism, facilitating informed decisions regarding diet and exercise for improved health outcomes.

LabLink

Seed Round in 2017
LabLink specializes in customizing laboratory reports to meet the specific requirements of healthcare providers, thereby facilitating the delivery of compliant and tailored reports for doctors and patients. The company transforms clinical lab data into a cohesive ecosystem that connects patients, providers, labs, hospitals, and insurance companies, promoting collaborative and value-driven applications of this data. By offering a shared source of truth, LabLink enables stakeholders to make informed care decisions while also supporting the creation of customized action plans for patients. The company’s tools aggregate and repurpose raw lab metrics into formats that serve diverse healthcare needs, aiding in areas such as insurance billing through ICD-10 code matching and generating large-scale public health reports. LabLink emphasizes the collaborative use of lab data among various healthcare players to enhance patient care and optimize health outcomes.

Myontec

Seed Round in 2017
Myontec Ltd., headquartered in Kuopio, Finland, specializes in developing, manufacturing, and marketing wearable sensory solutions designed to measure muscle activity and other bio-signals from the human body. The company's flagship product is Myontec Mbody, a pair of smart shorts equipped with real-time muscle sensing technology, accompanied by a mobile app for exercise analysis and tracking. Additionally, they offer the MyOnWear Research System for field studies and measurement services for various applications such as sports performance testing, coaching, research on occupational health, and biofeedback training.

Fruit Street

Series B in 2017
Fruit Street offers a virtual diabetes prevention program. It helps participants adopt healthier lifestyles to prevent type 2 diabetes through online classes, personalized tracking of diet and activity, and integration with wireless scales for progress monitoring.

StandLogix

Seed Round in 2016
StandLogix is a company focused on enhancing workplace wellness through its innovative sensor-based technology that promotes the use of standing desks. By providing reminders for users to alternate between sitting and standing, StandLogix helps employees incorporate healthy movement into their daily routines, effectively reducing mental and physical fatigue. The company's patent-pending sensor tracks users' sitting and standing times, allowing for personalized notifications based on individual body metrics and wellness goals. StandLogix's solution can be integrated into existing wellness platforms or used as a standalone application, featuring a user-friendly interface that encourages engagement through gamification and friendly competition. The data collected can also assist employers in understanding group health trends and optimizing desk utilization, potentially leading to reduced insurance premiums and improved risk assessment. Overall, StandLogix aims to maximize the health benefits of standing desks and foster a more productive work environment.

Multisensor Diagnostics

Seed Round in 2016
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

Patientory

Seed Round in 2016
Patientory is a digital health data platform that enables individuals to store and manage personal medical records and health information, empowering patients to control their data. The platform securely manages records, offers AI-driven health coaching, tracks wellness metrics, connects users to clinical trials and affordable medications, and rewards healthy behaviors. It facilitates connections between patients and healthcare providers to support care coordination. Founded in 2015 and based in Atlanta, the company aims to streamline access to health information and enable patients to benefit from their data.

SUPAspot

Seed Round in 2016
SUPA pays GenZ for their lifestyle data with tokens and offers stakeholder health through contextualized kits.

Sleep.ai

Venture Round in 2016
Sleep.ai develops wearable devices and mobile applications to diagnose and monitor sleeping disorders through mobile health solutions. The system detects snoring and grinding sounds and triggers a wearable to vibrate, prompting the user to shift position or adjust habits, with the goal of reducing disturbances. The app tracks sleep-related events over time and can be used in a shared sleep environment, since the device operates even when multiple people are sleeping in the same room. Data collected by the device and app supports ongoing assessment of sleep quality and disorder symptoms. By analyzing sound patterns and user activity, the technology helps healthcare professionals identify factors that influence sleep issues, such as alcohol use, smoking, and medications, facilitating targeted evaluation and management.

GenID Solutions

Seed Round in 2016
GenID Solutions is a healthcare technology company dedicated to preventing cancer through early detection and genetic innovation. The company has developed a platform that identifies patients at risk for hereditary cancers, allowing healthcare providers to prescribe preventive genetic treatments effectively. By focusing on genetics-focused clinical decision support, GenID Solutions offers a unique product that integrates seamlessly with existing electronic medical records (EMR) systems, requiring no additional training for users. The platform is designed to enhance patient outcomes by facilitating timely testing and intervention for those carrying cancer-related genes. Furthermore, GenID Solutions ensures compliance with HIPAA regulations, prioritizing patient privacy and data security in its mission to transform cancer care.

Qura

Venture Round in 2016
Founded in 2015, Qura develops ultra-miniature implantable devices for monitoring physiological pressure changes. These devices have the potential to transform biomedicine by enabling real-time disease monitoring and timely treatments.

OpenBeds

Seed Round in 2016
OpenBeds Inc. is a behavioral health technology company that has developed a cloud-based platform designed to enhance both inpatient and outpatient services. Founded in 2015 and headquartered in Washington, D.C., the company offers a suite of tools, including a real-time assessment tool that identifies and tracks behavioral health patients. OpenBeds provides evidence-based assessment tools, digital screening, therapy offerings, and social support resources, serving state networks, state governments, treatment facilities, and referral providers. Additionally, the platform significantly improves the inter-hospital patient transfer process, enhancing transparency and efficiency for both patients and healthcare institutions. OpenBeds operates as a subsidiary of Appriss Health since October 2019.

Mediktor

Venture Round in 2016
Mediktor is a developer of an advanced pre-diagnosis tool that utilizes artificial intelligence and natural language recognition to facilitate accurate symptom checking, triage, and decision-making support. The system is clinically validated and aims to transform healthcare by reducing access barriers for patients. It allows individuals to make informed decisions based on their initial symptoms while enabling healthcare providers to efficiently manage demand and optimize resources. Mediktor's technology connects patients with medical professionals within health insurance networks, assisting hospitals and health systems in making safe, rapid, and cost-effective healthcare decisions.

Care Technology

Seed Round in 2016
Care Technology Solutions, LLC, established in 2014 and based in Bethlehem, Pennsylvania, specializes in patient engagement and management solutions. It offers a comprehensive platform, Impresario, which streamlines patient engagement and care coordination, reducing Medicare fines, hospital readmissions, and unnecessary emergency calls. The company's software suite includes Home Care Connect for home healthcare process automation, Health Desk for process management, Automated Care Suite for personalized care plans, and Engagement Applications for patient-centric services. Care Technology's approach combines care orchestration, field service techniques, and behavioral integration to optimize resource deployment and identify patient risks.

Nonnatech

Seed Round in 2016
Nonnatech provides a device-agnostic digital health platform for senior care. It offers real-time patient monitoring, predictive analytics, and automated data transfer to caregivers, healthcare providers, and institutions. The platform focuses on early detection of physiological changes to prevent hospitalizations and reduce length of stay in rehabilitation facilities.

Titanovo

Seed Round in 2016
Titanovo offers a direct-to-consumer, saliva-based Telomere Testing Kit. Their telomere testing kit is the first of its kind which can be purchased online and used in the comfort of your own home, without any invasive bloodwork. Titanovo takes a step towards the next generation of modern healthcare by developing digital health tools for home-users, academic researchers, clinical practitioners, and corporate wellness.

RC21X

Seed Round in 2016
RC21X is a company that specializes in developing a web-based application designed to measure and monitor brain performance. Founded in 2014 and headquartered in Coraopolis, Pennsylvania, RC21X provides a user-friendly platform consisting of 15 brief, game-like modules that engage users while assessing their cognitive abilities. The application not only screens brain function but also generates personalized brain performance profiles, empowering users to take responsibility for their brain health and make informed decisions. Targeting both B2B and B2C markets, RC21X's services can be utilized in clinical settings or through a self-administered portal at home. By promoting brain health and neuroplasticity, the company aims to help individuals build mental reserves and mitigate age-related cognitive decline.

LS CancerDiag Oy

Seed Round in 2016
LS CancerDiag Ltd is committed to reducing cancer mortality rates with an efficient, simple diagnostic method that detects an inherited cancer-causing condition prior to cancer. Their vision is to see DiagMMR™ as a new global testing standard in LS diagnostics. Lynch syndrome is the main cause of hereditary colorectal cancers and it also causes a broad spectrum of other tumors. With a significant proportion of the world’s population carrying the Lynch syndrome mutation, there are potentially tens of millions under a severe risk for being affected by LS. Their groundbreaking DiagMMR™ assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome (previously known as Hereditary Non­Polyposis Colorectal Cancer; HNPCC). Their mission is to save lives through an innovation that dramatically simplifies diagnostics of Lynch syndrome by delivering predictive and accurate results with a fast, unique and cost-efficient method globally.

HLD Healthy Life Devices

Seed Round in 2016
HLD Healthy Life Devices Ltd. provides solutions to effectuate physiotherapeutic rehabilitation processes. It offers LymphaTouch, a measurement based treatment concept for edema removal. The company’s products are used in physical therapy centers, physiotherapy clinics, centers for physical rehabilitation, and patients' homes. It serves healthcare practitioners, such as physical therapists and professionals working in hospitals. HLD Healthy Life Devices Ltd. was founded in 2005 and is based in Espoo, Finland.

Flosonics Medical

Venture Round in 2016
Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

WinguMD

Venture Round in 2016
WinguMD, Inc., founded in 2013 and based in Palo Alto, California, is a privately held company specializing in mobile clinical communications and telehealth solutions. The company was established by Oliver Aalami, MD, and Manabu Tokunaga with the aim of enhancing care delivery workflows for physicians, suppliers, payers, and patients. WinguMD offers the ZenSnap® platform, which enables medical professionals to capture and share images for diagnostic purposes while ensuring security and compliance. The platform incorporates metadata collection and tagging tools, allowing for efficient and safe medical image analysis and collaboration.

openDoctor

Seed Round in 2016
OpenDoctor is a patient self-scheduling platform that facilitates the scheduling of medical appointments for patients, physicians, and healthcare staff. The company's cloud-based software as a service (SaaS) platform is designed to be fully integrated across a wide range of medical specialties, including family medicine and diagnostic imaging. It provides real-time scheduling capabilities, allowing patients to access healthcare services instantly. Additionally, OpenDoctor's platform supports the entire patient scheduling lifecycle, encompassing registration, payment processing, and analytics, thereby enhancing the overall patient engagement experience.

Cohero Health

Seed Round in 2015
Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.

Dermio

Seed Round in 2015
Dermio is a digital health platform that facilitates virtual consultations with certified dermatologists. Users can upload photos or videos of their skin conditions privately to the platform, which are then reviewed by dermatologists who provide personalized diagnosis and treatment plans. The platform also offers prescription services sent to users' preferred pharmacies.

CNS Therapy

Seed Round in 2015
CNS Therapy is a spin-off from the University of North Carolina that develops mind-body therapy-based solutions and devices to alleviate chronic pain and related conditions. It combines operant behavioral therapy with a proprietary device called SET, Systolic Extinction Training, to enhance learning and reset the autonomic nervous system, with the aim of delivering long-lasting pain relief. The company tracks physiological parameters and uses the resulting data to optimize therapy, delivering an integrated program of psychological training and electrostimulation to help patients reduce or eliminate pain and return to daily activities.

Share Practice

Seed Round in 2015
Share Practice is a company that provides a collaborative clinical reference platform designed for healthcare professionals. It has developed a mobile application that aggregates information from various medical databases, offering access to thousands of diagnoses. This tool enables doctors to identify and understand the most effective clinical treatments by leveraging the experiences and successes of their peers. Additionally, the platform allows for feedback and reviews of conventional therapies, while also incorporating new and integrative medicine approaches. By facilitating knowledge sharing among doctors, Share Practice aims to enhance clinical decision-making and improve patient outcomes.

Joint Academy

Venture Round in 2015
Joint Academy is a digital health platform that connects patients with licensed physical therapists to deliver evidence‑based online treatment for chronic joint and back pain, including osteoarthritis. The app offers individualized exercise plans, interactive education, and progress tracking, enabling therapists to manage symptoms and reduce reliance on medication. Clinical studies show patients experience pain reduction, reconsideration of surgery, and decreased painkiller use. The service is available in Sweden, the US, the UK, France, and Germany.

Stethos

Seed Round in 2015
Stethos is a company that specializes in the design and development of high-quality electronic stethoscopes. Its innovative product is engineered to capture minute responses from the lungs and heart, providing healthcare providers with advanced tools for monitoring, recording, and replaying vital sounds. By enhancing the diagnostic process, Stethos aims to improve the accuracy and efficiency of patient assessments in clinical settings.

Virtual Viewbox

Seed Round in 2015
Virtual Viewbox is a company that specializes in software solutions designed to enhance collaboration and interoperability among medical providers and attorneys. Established in 2010, it developed RadCloud, a HIPAA-compliant, private cloud-based platform that facilitates the delivery of radiology services. The company's focus is on addressing interoperability challenges in the medical field by creating innovative technologies in medical informatics. Virtual Viewbox holds multiple pending patents that target key issues in medical data sharing and interoperability, particularly between electronic medical record systems and proprietary medical enterprises. Its platform enables physicians to streamline the sharing of patient information, consolidating records from various picture archiving and communications systems into a single interface, which supports virtual consultations with radiologists. Through its advancements, Virtual Viewbox aims to improve the efficiency of medical data exchange and enhance patient care over the next several years.

Breathresearch

Seed Round in 2015
BreathResearch, Inc., based in Walnut Creek, California, specializes in developing portable spirometers and applications for tracking and early detection of respiratory ailments. Founded in 2008, the company focuses on converting the air waves from breathing into sound waves, which allows for advanced respiratory analytics aimed at improving health, fitness, and performance. BreathResearch is also working on new wearable technology to simplify and make affordable cardiorespiratory assessments accessible to both athletes and patients at risk for heart or lung diseases. Its flagship device, Breath Acoustic, leverages breath analysis to detect lung and heart conditions, providing valuable tools for lifestyle consumers and individuals with chronic health issues to monitor their cardiorespiratory fitness and facilitate early detection of potential health complications.

Dynofit

Seed Round in 2015
Dynofit, Inc. is a technology company that develops applications and software to enhance physical therapy through the integration of sensors and mobile technologies. Founded in 2012 and headquartered in Los Alamos, New Mexico, Dynofit focuses on making rehabilitation accessible in home settings for individuals suffering from neuro-muscular impairments due to conditions such as stroke, cerebral palsy, and spinal cord injuries. One of its key offerings is a mobile application and clinical dashboard known as DOTs, which utilizes electromyography (EMG) biofeedback to measure, digitize, and store therapy-related data. This system aims to increase patient engagement and provide therapists with valuable insights into patient progress between clinical visits, ultimately enhancing the overall effectiveness of therapeutic interventions.

Skindroid

Venture Round in 2015
Skindroid, founded in 2014 by Winston Capel and Somair Riaz, is a Colorado-based company that specializes in the manufacturing and distribution of innovative skin biosensors for wearable devices. The company focuses on developing intelligent sensors that enable non-invasive monitoring of skin-based sweat through IoT technology. Skindroid's devices analyze molecules in sweat, providing automatic biometric readouts via a mobile application. This functionality allows users to optimize their workouts and prevent injuries by gaining deeper insights into their physiological data.

Clariflow

Seed Round in 2014
ClariFlow is a clinically proven and patented DIY device for men to identify early signs of BPH. Urologists also get patient referrals through their mobile app. ClariFlow is the first home test for BPH. Developed over 10 years by researchers in Europe and clinically tested around the world including UCLA, ClariFlow lets you test for maximum urinary flow rate, which is one of the indicators of BPH. Simply preorder the kit online here. It’ll get shipped to you in a discreet package. In conjunction with your symptoms checklist, the easy-to-read gauge will tell you if you’re at risk for BPH. BPH is short for Benign Prostatic Hyperplasia. It means that your prostate is enlarged and this may cause problems with you ability to urinate. For example, you may feel that you’re urinating more frequently than before or that you’re unable to urinate completely. Perhaps your urination interferes with your ability to sleep through the night or you’re getting more urinary tract infections. These are all potential signs that you may have BPH. BPH is very common. Half of men over 50 years old experience this condition, as do 75% of men over 80. Even men in their 30s can begin to experience the symptoms, so you or your loved one is far from being alone. Early diagnosis of BPH is really important. Once you and your doctor know that you have BPH, there are medications that you can take to reduce the need for frequent urination and the uncomfortable feelings associated with BPH. Finding out early also reduces the chances that you’ll need surgery later on to correct for your symptoms. And lastly, it’s always a good idea to rule out more serious conditions, such as prostate cancer, as soon as you can, because they sometimes present similar symptoms. BPH can be easily treated if diagnosed early. If left untreated, it can lead to urinary tract infections, incontinence, urinary retention, and other unpleasant symptoms. Extreme cases may call for the use of a catheter in order to empty the bladder, or even surgical intervention.

AprilAge

Venture Round in 2014
AprilAge Inc., founded in 2010 and based in Toronto, Canada, specializes in developing visualization software aimed at promoting health behavior change. The company's products include forme, a tool for predicting changes in Body Mass Index (BMI) over time, and April, a face aging software that illustrates how lifestyle behaviors such as obesity, smoking, and excess sun exposure will affect one's appearance as they age. These tools are designed to motivate individuals by providing personalized visualizations of the impacts of risky lifestyles on their health. The software is used by health and wellness providers, insurers, and employers in over 30 countries to engage patients and customers in adopting healthier behaviors that can prevent chronic diseases.

LuminaCare Solutions

Seed Round in 2014
LuminaCare Solutions offers a cloud-based predictive analytics software that personalizes antibacterial treatments for patients. Its proprietary technology swiftly guides the selection of appropriate antibiotics within 24 hours, reducing hospital stays and care costs. This improves patient outcomes and decreases mortality rates associated with hard-to-treat bacterial infections.

Accel Diagnostics

Seed Round in 2014
Accel Diagnostics, LLC is a medical diagnostics company based in Pittsburgh, Pennsylvania, founded in 2008. The company develops innovative diagnostic technologies, including the pScreen Card, a disposable, credit-card-sized blood diagnostic platform that detects and quantifies biomarkers through a companion mobile application. This lab-on-chip technology allows for rapid diagnosis of infectious and chronic diseases at the point-of-care, delivering accurate results within 30 minutes and enhancing the quality of care while reducing costs. Additionally, Accel Diagnostics focuses on heart failure management, enabling patients to monitor their condition at home and allowing timely responses to heart distress before severe symptoms arise. This approach aims to reduce life-threatening events and prevent costly hospitalizations, representing a significant advancement in patient care for congestive heart failure.

UnaliWear

Seed Round in 2014
UnaliWear Inc. is a Texas-based company founded in 2013 that creates advanced wearable technology designed to enhance the independence and safety of seniors. Its flagship product, the Kanega watch, is often likened to an "OnStar for People," offering discreet support for falls, medication reminders, and guidance for those at risk of wandering. The watch features a user-friendly speech interface, eliminating the need for buttons, and incorporates a patented battery system, allowing continuous use without the necessity for recharging. Built with integrated cellular, Wi-Fi, GPS, and Bluetooth technologies, the Kanega watch provides round-the-clock medical alerts and utilizes artificial intelligence to learn and adapt to the wearer’s lifestyle. This innovative approach aims to empower vulnerable seniors by ensuring they receive timely assistance while maintaining their dignity and independence.

Health 123

Seed Round in 2014
Health 123, Inc. operates health123.com, an online platform designed to help individuals enhance their health through personalized guidance. Founded in 2011 and based in Seattle, Washington, the company offers tools that enable users to track and understand key health metrics, including weight management, heart health, nutritional balance, energy levels, and emotional wellness. In addition to these resources, Health 123 sells a variety of products online, including supplements, blood test kits, books, scales, and health tracking devices. The company also provides a Health Activation Platform that fosters patient engagement by delivering curated content, personalized care plans, and direct communication with healthcare teams. This platform is designed to improve health literacy and empower users, ultimately leading to better health outcomes and increased patient satisfaction. As of January 2017, Health 123 operates as a subsidiary of Samepage Inc.

Tickit Health

Seed Round in 2013
Tickit Health develops a patient engagement platform focused on mental health screening and navigation. Its interactive questionnaires enable healthcare organizations worldwide to identify at-risk patients efficiently, improving outcomes across the care continuum.

Cohero Health

Seed Round in 2013
Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.

Respondwell

Seed Round in 2013
RespondWell, LLC is a digital health company that specializes in telerehabilitation technology. Founded in 2003 and based in Grand Rapids, Michigan, the company offers a comprehensive platform designed for patients, outpatient rehabilitation clinics, hospital systems, and senior care facilities. RespondWell provides a range of modules, including prevention and rehabilitation, as well as clinical content and clinician tools, facilitating patient assessment, engagement, and reporting. The platform supports total joint replacement patients by enabling healthcare providers to connect and monitor patients while collecting valuable data. Patients can access instructional videos for physical therapy conducted by virtual instructors, enhancing their rehabilitation experience. RespondWell also features engagement incentives through in-product rewards and offers two specific online programs, Therapy@Home and Fitness@Home. The company became a subsidiary of Zimmer Biomet Signature Solutions in October 2016.

Datagenno Interactive Research

Seed Round in 2013
Datagenno Interactive Research is a company focused on bridging the gap between molecular and clinical genetics, specifically in the context of rare diseases and challenging diagnoses. It specializes in developing tailored research strategies for various projects, enhancing the understanding of genetic conditions. The company operates an interactive online database platform that provides comprehensive information on genetic diseases and syndromes. This platform serves as a valuable resource for health professionals, facilitating their clinical practices by integrating both clinical and molecular aspects of genetic diseases within an interactive environment.

@Point of Care

Seed Round in 2013
Point of Care operates a multiplatform application designed to enhance patient care by collecting and analyzing data from patients to support clinicians in making informed treatment decisions. Founded in 2012 by Robert Stern and headquartered in Livingston, New Jersey, the company's app facilitates the synchronization of patient information during consultations, allowing healthcare practitioners to access diagnostic and treatment adherence data. For patients, the platform offers reminders, achievement alerts for treatment adherence, and relevant health information from reputable organizations. Additionally, Point of Care provides healthcare practitioners with insights into medical advancements and treatment breakthroughs, fostering a reliable environment for patient outreach and population management. By leveraging innovative health information technology, the company aims to improve treatment regimens and enable effective monitoring of patient health.

RxApps

Venture Round in 2013
RxApps is a developer of a management application aimed at enhancing patient compliance in self-management of chronic illnesses. The company utilizes customizable text message prompts to monitor various health metrics, such as mood and weight, allowing patients to easily respond with quantitative data. This real-time information supports both patients and healthcare providers in evaluating treatment effectiveness, identifying challenging lifestyle factors, and assessing the risk of adverse clinical outcomes, including hospitalizations. By fostering improved communication and self-monitoring, RxApps encourages behavior change among patients, making care management more personal and informed. The company's approach emphasizes the significance of the patient experience in treatment adherence, particularly for those with co-occurring conditions like depression, which can complicate care. Through its services, RxApps aims to create a more engaging and supportive healthcare environment, ultimately improving the quality of life for its users and promoting better self-care practices.

Arpeggi

Seed Round in 2013
Arpeggi, Inc. specializes in genome sequencing, data management, and computational analysis services tailored for the medical and life sciences sectors. Established in 2012 and located in Austin, Texas, the company offers a comprehensive range of services, including sequence development, genome reconstruction, mutation detection, and pathway analysis. By managing the entire process from sample preparation to computational analysis and interpretation, Arpeggi aims to maximize the value derived from genomic data for its clients.

Cerora

Venture Round in 2013
Cerora, Inc. is a healthcare information technology company based in Bethlehem, Pennsylvania, specializing in neuro diagnostic solutions for conditions such as mild traumatic brain injury (mTBI) and Alzheimer’s disease. Founded in 2011, Cerora has developed MindReader, a portable neuro diagnostics-as-a-service technology that monitors brain health and aids in the diagnosis of various neurological conditions, including mTBI, mild cognitive impairment, and neuropsychiatric disorders. The company's innovative products also support applications in sports concussion management and the development of pharmaceutical compounds. By providing objective, biomarker-based diagnostic information, Cerora enables clinicians to make informed decisions and improve patient outcomes in the realm of brain health.

WalkJoy

Seed Round in 2013
WalkJoy Inc. is a California-based company that specializes in developing devices and diagnostic platforms aimed at addressing fall risks, peripheral neuropathy, and various walking health issues. Founded in 2010 and located in Long Beach, WalkJoy offers a therapy device designed to reduce falls and foot ulcers while aiding patients in restoring their balance and gait. Additionally, the company has developed WalkingHealth, a diagnostic tool utilized by therapists and care facilities to identify and document gait abnormalities in patients. By focusing on these critical health challenges, WalkJoy seeks to improve walking conditions for individuals, particularly the elderly and those with peripheral neuropathy, while also aiming to reduce related healthcare costs.

Care At Hand

Venture Round in 2013
Care At Hand, Inc. is a digital health company based in San Francisco, California, specializing in mobile-based electronic health records and workflow automation software tailored for home health care agencies. The company aims to enhance patient care by utilizing evidence-based predictive algorithms, which convert point-of-care observations from home health aides into clinically relevant alerts for clinicians. This innovative approach helps identify early medical and psychosocial risk factors that may lead to hospitalization, thereby enabling timely interventions. Care At Hand operates as a subsidiary of Mindoula Health, Inc. and offers its software as a service (SaaS) to payers and providers, focusing on improving outcomes-based reimbursement and leveraging existing frontline staff to optimize care delivery. The platform also allows family members to access medical information, promoting transparency and engagement in patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.